Several physicians who spoke with Healio Primary Care applauded the FDA’s decision to make Pataday Twice Daily Relief and Pataday Once Daily Relief available over the counter to patients 2 years of age and older with itchy eyes associated with allergic conjunctivitis.
However, one expert expressed concern that the FDA’s decision is part of a larger trend that may put allergy medication out of the reach of some patients and may even put their health at risk.
Previously, Pataday Twice Daily Relief (olopatadine HCl ophthalmic solution/drops 0.1%, Alcon) and Pataday (Read more...)
Uncategorized